According to Anthropic (@AnthropicAI), the company has introduced Claude for Life Sciences, an AI platform designed to support research across the life sciences sector, from early discovery phases to commercialization. Claude now features integrated connectors to existing scientific tools, specialized AI Skills, and new industry partnerships, significantly enhancing its utility for scientific workflows and accelerating data analysis, hypothesis generation, and collaboration within pharmaceutical and biotech industries. These advancements aim to streamline R&D processes and enable faster go-to-market strategies for life sciences companies (source: Anthropic, Oct 20, 2025).

According to Google DeepMind on Twitter, the development of a universal AI assistant is paving the way for future artificial intelligence systems capable of independently conducting scientific research, which could lead to breakthrough medical solutions and 'miracle cures.' Google DeepMind has been recognized as one of TIME’s 100 Most Influential Companies and received an Impact Award for its contributions to advancing AI technologies. This recognition highlights DeepMind's role at the forefront of AI-driven innovation, especially in automating complex research tasks, accelerating drug discovery, and creating new business opportunities for AI-powered scientific tools. The announcement underlines the growing market for AI assistants in the scientific and healthcare sectors, emphasizing the commercial and societal potential of intelligent research automation (Source: @GoogleDeepMind, Twitter, June 30, 2025).